XML 27 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Cash flows from operating activities:          
Net loss $ (58,763) $ (31,847) $ (160,345) $ (49,815)  
Adjustments to reconcile net loss to net cash provided by operating activities:          
Management fee 11,823 3,712 28,073 3,712  
Performance participation allocation 12,447 5,711 29,796 10,952 $ 17,000
Performance participation allocation       10,952  
Depreciation and amortization 103,758 40,359 262,708 65,145  
Unrealized gain on changes in fair value of financial instruments     (8,761) (993)  
Other items     (880) (20)  
Change in assets and liabilities:          
(Increase) / decrease in other assets     (53,117) (10,824)  
Increase / (decrease) in due to affiliates     234 3,859  
Increase / (decrease) in accounts payable, accrued expenses, and other liabilities     81,340 22,244  
Net cash provided by operating activities     179,048 44,260  
Cash flows from investing activities:          
Acquisitions of real estate     (5,693,880) (2,245,885)  
Capital improvements to real estate     (59,071) (3,290)  
Pre-acquisition costs       (9,201)  
Purchase of real estate-related securities     (1,227,708) (660,151)  
Proceeds from settlement of real estate-related securities     124,396 16,596  
Net cash used in investing activities     (6,856,263) (2,901,931)  
Cash flows from financing activities:          
Proceeds from issuance of common stock     1,948,928 1,264,053  
Offering costs paid     (31,316) (15,388)  
Subscriptions received in advance     180,425 98,435  
Repurchase of common stock     (19,259) (187)  
Redemption of redeemable non-controlling interest     (8,400) 0  
Borrowings from mortgage notes, term loans, and revolving credit facilities     5,632,422 1,055,913  
Repayments from mortgage notes, term loans, and revolving credit facilities     (1,737,931) 0  
Borrowings under repurchase agreements     954,892 491,026  
Settlement of repurchase agreements     (96,025) (12,571)  
Borrowings from affiliate line of credit     1,135,900 617,650  
Repayments on affiliate line of credit     (1,141,150) (495,150)  
Payment of deferred financing costs     (39,468) (12,384)  
Contributions from non-controlling interests     80,216 8,978  
Distributions to non-controlling interests     (2,776) 0  
Distributions     (38,075) (6,203)  
Net cash provided by financing activities     6,818,383 2,994,172  
Net change in cash and cash equivalents and restricted cash     141,168 136,501  
Cash and cash equivalents and restricted cash, beginning of period     157,729 200 200
Cash and cash equivalents and restricted cash, end of period 298,897 136,701 298,897 136,701 157,729
Reconciliation of cash and cash equivalents and restricted cash to the condensed consolidated balance sheets:          
Cash and cash equivalents 75,529 30,820 75,529 30,820 31,166
Restricted cash 223,368 105,881 223,368 105,881 126,563
Cash and cash equivalents and restricted cash, end of period $ 298,897 $ 136,701 298,897 136,701 $ 157,729
Non-cash investing and financing activities:          
Assumption of mortgage notes in conjunction with acquisitions of real estate     197,290 107,369  
Assumption of other liabilities in conjunction with acquisitions of real estate     51,094 17,093  
Acquired non-controlling interests     12,802 0  
Accrued capital expenditures and acquisition related costs     3,985 314  
Accrued pre-acquisition costs     61 905  
Accrued distributions     9,952 5,624  
Accrued stockholder servicing fee due to affiliate     101,124 75,998  
Accrued offering costs due to affiliate       7,552  
Redeemable non-controlling interest issued as settlement of performance participation allocation     16,974 0  
Allocation to redeemable non-controlling interest     1,826 0  
Distribution reinvestment     66,899 13,494  
Accrued common stock repurchases     $ 11,344 $ 152